Ancestry Bias in Cancer Genomic Databases and Its Consequences for Variant Interpretation in African Populations
Sr No:
Page No:
38-44
Language:
English
Authors:
Badie Moupain Idriss*
Affiliation:
Departement of microbiology, hematology and immunology, Faculty of medicine and pharmaceutical sciences, university of Dschang, B.P. 96 Dschang, Cameroon
Received:
2026-09-06
Accepted:
2026-10-16
Published Date:
2026-11-21
Abstract:
African populations are strikingly underrepresented in cancer genomic databases,
threatening the accuracy of variant interpretation for patients of African ancestry. This narrative
review examines the sources, mechanisms, and clinical consequences of ancestry bias in cancer
genomics, with emphasis on somatic and germline resources including The Cancer Genome
Atlas (TCGA), the International Cancer Genome Consortium (ICGC), AACR Project GENIE,
gnomAD, and ClinVar. We describe how reference genomes, allele-frequency databases, genepanel design, and tumour-only germline filtering propagate European-ancestry bias into variant
classification. The consequences include elevated rates of variants of uncertain significance
(VUS), misclassification of pathogenic and benign alleles, and limited transferability of
polygenic risk scores. Evidence from breast, prostate, cervical, and colorectal cancers in African
and African-ancestry populations illustrates these harms with concrete numbers. Initiatives such
as H3Africa, regional genome projects, local reference panels, and data-governance frameworks
offer partial remedies, but sustained investment, capacity building, and equitable data-sharing
are needed. We recommend ancestry-aware variant curation, expanded African reference data,
and revised classification criteria that account for population-specific allele frequencies.
Without these steps, precision oncology will continue to deliver unequal benefit
Keywords:
African ancestry; cancer genomics; variant interpretation; ancestry bias; health disparities; precision oncology.